Moreover, to investigate whether tumor aggressiveness and abnormal glucose metabolism induced by p53 mutants were MGAT4A‐dependent in EC cells, siRNA targeting MGAT4A was used to inhibit MGAT4A expression in Ishikawa shp53 3’UTR cells (Figure S5E, Supporting Information). The gene discussed is MGAT4A; the disease is neoplasm.